Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 01 11 2020
accepted: 29 12 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 13 1 2021
Statut: epublish

Résumé

This study describes the occurrence of a silent mutation in the RNA binding domain of nucleocapsid phosphoprotein (N protein) coding gene from SARS-CoV-2 that may consequence to a missense mutation by onset of another single nucleotide mutation. In the DNA sequence isolated from severe acute respiratory syndrome (SARS-CoV-2) in Iran, a coding sequence for the RNA binding domain of N protein was detected. The comparison of Chinese and Iranian DNA sequences displayed that a thymine (T) was mutated to cytosine (C), so "TTG" from China was changed to "CTG" in Iran. Both DNA sequences from Iran and China have been encoded for leucine. In addition, the second T in "CTG" in the DNA or uracil (U) in "CUG" in the RNA sequences from Iran can be mutated to another C by a missense mutation resulting from thymine DNA glycosylase (TDG) of human and base excision repair mechanism to produce "CCG" encoding for proline, which consequently may increase the affinity of the RNA binding domain of N protein to viral RNA and improve the transcription rate, pathogenicity, evasion from human immunity system, spreading in the human body, and risk of human-to-human transmission rate of SARS-CoV-2.

Identifiants

pubmed: 33407800
doi: 10.1186/s13104-020-05439-x
pii: 10.1186/s13104-020-05439-x
pmc: PMC7787625
doi:

Substances chimiques

Coronavirus Nucleocapsid Proteins 0
Phosphoproteins 0
RNA, Viral 0
nucleocapsid phosphoprotein, SARS-CoV-2 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Références

Bioinformatics. 2018 Nov 1;34(21):3755-3758
pubmed: 29850778
Front Immunol. 2019 Oct 01;10:2347
pubmed: 31632411
J Virol. 2010 Nov;84(21):11418-28
pubmed: 20719948
Viruses. 2014 Aug 07;6(8):2991-3018
pubmed: 25105276
Viruses. 2012 Jun;4(6):1011-33
pubmed: 22816037
Biol Proced Online. 2020 Apr 21;22:8
pubmed: 32336957
J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8
pubmed: 23977429
Protein Sci. 2018 Jan;27(1):135-145
pubmed: 28884485
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):E838-47
pubmed: 23401522
Diseases. 2016 Jul 25;4(3):
pubmed: 28933406
J Virol. 2010 Feb;84(4):2169-75
pubmed: 19955314
Virology. 2012 Oct 25;432(2):485-94
pubmed: 22832120
J Virol. 2015 Nov;89(22):11383-95
pubmed: 26339053
PLoS Pathog. 2010 Nov 04;6(11):e1001176
pubmed: 21079686
BMJ. 2020 Mar 12;368:m1036
pubmed: 32165426
Adv Virus Res. 2016;96:165-192
pubmed: 27712623
Curr Opin Virol. 2014 Jun;6:55-60
pubmed: 24762977
PLoS Biol. 2015 May 05;13(5):e1002140
pubmed: 25942442
Vaccine. 2015 Dec 8;33(49):6955-66
pubmed: 26603954
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Nucleic Acids Res. 2015 Jan;43(Database issue):D571-7
pubmed: 25428358
Biol Proced Online. 2020 Jun 19;22:11
pubmed: 32572334
J Enzyme Inhib Med Chem. 2016;31(sup4):176-184
pubmed: 27557594
Eur J Biochem. 2003 Oct;270(20):4070-81
pubmed: 14519118
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466

Auteurs

Reza Zolfaghari Emameh (R)

Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), 14965/161, Tehran, Iran. zolfaghari@nigeb.ac.ir.

Mahyar Eftekhari (M)

Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), 14965/161, Tehran, Iran.

Hassan Nosrati (H)

Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.

Jalal Heshmatnia (J)

Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Reza Falak (R)

Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH